Search bioRxivSearch

Biology subjects

Peter Waweru Mwangi

Publications and source records attributed to Peter Waweru Mwangi.

2 recordsLinked to original sources

FREEZE DRIED EXTRACTS OF Bidens biternata (Lour.) Merr. And Sheriff. SHOW SIGNIFICANT ANTIDIARRHEAL ACTIVITY IN -VIVO MODELS OF DIARRHEA

Ethnopharmacological relevance of the studyDiarrhea remains one of the main killers of children aged below five years. Traditional antidiarrheal remedies form a potentially viable source of novel low cost efficacious antidiarrheal remedies in low resource settings. There is therefore a pressing to scientifically evaluate these remedies.\n\nAim of the studyThis study aimed to investigate the in vivo and in vitro antidiarrheal activity of Bidens biternata a herb species used in traditional Ayurvedic medicine in the management of diarrhea.\n\nMaterials and MethodsIn the castor oil test twenty (20) adult Sprague-Dawley rats were randomized to the negative control (normal saline), positive control (5 mg/kg loperamide), (200 mg/kg Bidens biternata extract) and (400 mg/kg Bidens biternata extract) groups (n=5 in each group). Castor oil (4 ml/kg) was then administered to the animals one hour after administration of the respective treatments after which the total mass of fecal output excreted after four (4) hours was determined.\n\nIn the charcoal meal test fifteen (15) Sprague Dawley rats were randomized to the negative control (normal saline 5 ml/kg orally), the positive control (atropine sulphate 0.1 mg/kg i.p) and test (400 mg/kg Bidens biternata extract) groups (n=5). Charcoal meal was then administered via oral gavage to each rat thirty (30) minutes after the administration of the various treatments. The distance covered by the charcoal meal from the pylorus was then determined after sacrifice of the animals.\n\nIn the enteropooling test twenty (20) Sprague-Dawley rats were randomized to the negative control (5% v/v ethanol in normal saline), positive control (5 mg/kg loperamide) and test (400 mg/kg Bidens biternata extract) groups and prostaglandin E2 (PGE2) (100g/kg) administered immediately after the treatments. The animals were then sacrificed half an hour later and the volume of the small intestine contents determined. The effects of different concentrations of Bidens biternata extract (0.5. 1.0, 2.0, 3.0 and 5.0 mg/ml) on jejunal contraction were investigated and a dose-response curve constructed using the experimental data after which The ED50 dose determined. The effect of tamsulosin (1 adrenergic blocker), yohimbine (2 adrenergic blocker), propranolol ({beta} adrenergic blocker) and naloxone ( opioid blocker) on the contractile activity of the extract were also investigated.\n\nThe experimental data were expressed as mean {+/-} standard error of mean (SEM) and then analyzed using one way ANOVA followed by Tukeys post hoc test in cases of significance (set at p<0.05).\n\nResultsThe freeze dried extracts of Bidens biternata had significant antidiarrhealeffects in the castor oil induced diarrhea model (p=0.0075) with maximal activity being observed at the 400mg/kg dosage level (1.66{+/-} 0.81g vs. 4.54 {+/-} 0.51 g negative control, p=0.01). Bidens biternata extract had significant effects on intestinal motility in the charcoal meal test compared to the control group (43.61 {+/-} 4.42% vs. 60.54 {+/-} 3.33%: p= 0.02). Bidens biternata extract had a significant effect on PGE2 induced enteropooling (3.06 {+/-} 0.07 ml vs. 4.74 {+/-} 0.10 ml; p<0.001).\n\nThe freeze dried extracts of Bidens biternata had a significant negative effect on the contractility of the isolated rabbit jejunum (p<0.001). The effects of the extract were significantly attenuated by tamsulosin (53.94 {+/-} 4.20% vs. 80.57 {+/-} 4.09%; p=0.0067) and naloxone (53.94 {+/-} 4.20% vs. 73.89 {+/-} 7.26 %; p=0.0358). Yohimbine (p=0.4598) and propranolol (p=0.5966) however did not have any significant effect on the contractile activity of the extract.\n\nConclusionsThe freeze dried extract of Bidens biternata possess significant antidiarrhealactivity in both in vitro and in vivo models which appears to be mediated by modulating both the intestinal motility as well as the secretory activity. The results of this study also validate its traditional use as an antidiarrheal remedy.\n\n\n\nO_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=196 SRC=\"FIGDIR/small/046185_ufig1.gif\" ALT=\"Figure 1000\">\nView larger version (15K):\norg.highwire.dtl.DTLVardef@1251d73org.highwire.dtl.DTLVardef@1b08654org.highwire.dtl.DTLVardef@430f4forg.highwire.dtl.DTLVardef@a210cc_HPS_FORMAT_FIGEXP M_FIG C_FIG

Pharmacology and Toxicology

Pre-treatment with the methanol extract of Withania somnifera prevents Diazinon -induced cardiotoxic effects of organophosphate poisoning

Organophosphate poisoning represents a major and growing global health problem especially in the developing countries and cardiotoxicity is the major cause of death. Thus, a compelling need to develop novel low cost efficacious agents to manage this condition.\n\nObjectiveTo evaluate the methanol extract of Withania somnifera as a pre-treatment agent in the prevention of the cardiotoxic effects of diazinon in Sprague Dawley rats\n\nMaterials and MethodsTwenty one (21) adult rats were randomized to receive 200 mg/kg methanol extract of Withania somnifera (test group), vehicle (negative control) or 200 g/kg Neostigmine as pre-treatment 30 minutes prior to the oral administration of 200 mg/kg Diazinon. Baseline and post-treatment electrocardiograms (ECGs) were recorded by the Powerlab data acquisition system (ML865 AD instruments, Sydney, Australia). The experimental data were expressed as median {+/-} the inter-quartile range and analysed using the Kruskal - Wallis non-parametric test and followed by Mann-Whitney U post hoc test in cases of significance, which was set at p < 0.05. Statistical Package for Social Sciences (SPSS) version 17 software was used for analysis.\n\nResultsPre-treatment with the methanol extract of W. somnifera had significant effect on the following diazinon-induced electrocardiographic changes; RR interval (0.026 (0.007 - 0.065) vs. 0.035 (0.019 - 0.050) vs. 0.090 (0.071 - 0.01), p = 0.031),heart rate (-54.235 (-115.317 - (-19.857)) vs. --96.136 (-96.472 - (-43.879)) vs. --174.361 (-189.775 - (-129.469)), p = 0.014), PR interval (0.006 (0.004 - 0.008) vs. 0.003 (0.001 - 0.004) vs. 0.009 (0.006 - 0.015), p = 0.019), QRS interval (0.005 (0.001 - 0.008) vs. --0.002 (-0.005 - 0.001) vs. 0.007 (0.003 - 0.011), p = 0.023) and ST height (-34.830 (-63.578 - 4.215) vs. --22.330 (-38.383- (-4.159)) vs. --73.156 (-214.022- (-52.449)), p = 0.023). It however had no significant effect on the QTc interval changes (-0.005 (-0.011 - 0.003) vs. --0.005 (-0.015 - 0.065) vs. --0.021 (-0.060- (-0.006)), p = 0.174).\n\nConclusionThe efficacy of pre-treatment with the methanol extract of Withania somnifera was comparable to that of pre-treatment with Neostigmine a commonly used carbamate drug. Thus, it is a potentially viable low cost treatment option for organophosphate poisoning in resource-limited settings.

Physiology